December 23, 2010

Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

November 16, 2010

A Food and Drug Administration advisory committee has recommended expanded approval of a vaccine for...

February 17, 2010

A vaccine made by Merck for preventing human papillomavirus works for preventing anal warts and...